Skip to main content
placeholder image

4011 POSTER Results of a phase 3, randomized study of patients with advanced renal cell carcinoma (RCC) and poor prognostic features treated with temsirolimus, interferon-a or the combination of temsirolimus + interferon-a

Journal Article


Abstract


UOW Authors


  •   De Souza, Paul (external author)

Publication Date


  • 2007

Citation


  • de Souza, P., Maart, K., Laurell, A., Hawkins, R. E., Berkenblit, A., Galand, L., . . . Hudes, G. (2007). 4011 POSTER Results of a phase 3, randomized study of patients with advanced renal cell carcinoma (RCC) and poor prognostic features treated with temsirolimus, interferon-a or the combination of temsirolimus + interferon-a. European Journal of Cancer Supplements, 5(4), 282-283. doi:10.1016/s1359-6349(07)71079-0

Web Of Science Accession Number


Start Page


  • 282

End Page


  • 283

Volume


  • 5

Issue


  • 4

Abstract


UOW Authors


  •   De Souza, Paul (external author)

Publication Date


  • 2007

Citation


  • de Souza, P., Maart, K., Laurell, A., Hawkins, R. E., Berkenblit, A., Galand, L., . . . Hudes, G. (2007). 4011 POSTER Results of a phase 3, randomized study of patients with advanced renal cell carcinoma (RCC) and poor prognostic features treated with temsirolimus, interferon-a or the combination of temsirolimus + interferon-a. European Journal of Cancer Supplements, 5(4), 282-283. doi:10.1016/s1359-6349(07)71079-0

Web Of Science Accession Number


Start Page


  • 282

End Page


  • 283

Volume


  • 5

Issue


  • 4